[Download Now] Psychopharmacology 2-Day Conference – Perry W. Buffington

Salepage_https://catalog.pesi.com/item/24536/
Archive: https://archive.fo/wip/y77z6

Learn current understanding of how & why mental health medications work
Understand which medications are evidenced-based to best treat which disorders
Improve your clients’ responses and clinical outcomes to medications
Help your clients recognize side effects and learn how to manage them
Learn about new trends in prescribing
Understand current controversies in the field
New and emerging ethical dilemmas both prescribing and non-prescribing clinicians face daily

Spend two action-packed days learning about the newest advances in psychopharmacology and contemporary trends in medication management. From his unique perspective, Dr. Perry Buffington teaches psychopharmacology thoughtfully, with an emphasis on the experience of the client. Dr. Buffington’s years of experience in mental health and passion for clients, shines through in the detail and thoroughness of his presentation.

Clients often only have a few minutes with their prescriber and require additional support. It’s vital that you are able to answer their questions, help manage side effects and understand reactions. Designed for counselors, nurses, psychotherapists, psychologists, and other mental health professionals, Dr. Buffington provides the information you need in order to best help your clients.

This conference allows time for exploration of underrepresented areas, including ADHD, substance use disorders and psychopharmacological ethics. Take home specialized guidelines for geriatrics, and clients with chronic pain. Discuss how the DSM-5® and the Affordable Healthcare Law have impacted prescribing patterns and the use of psychotropics in newly defined diagnoses. In addition to a general ‘nuts and bolts’ review of medications, you will examine case examples, discuss medication controversies and how to effectively collaborate with prescribing practitioners. You will find this conference to have the most up- to-date medication information and how to use it most effectively with your client.

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs

We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

Analyze the historical antecedents of psychopharmacological products and their relation to today’s psychotropic medications.
Designate the mechanism of action of today’;s psychotropic medications and how it relates to your clients.
Breakdown the process of medication selection and receptor activation/blocking for specific disorders.
Communicate the side effects including nutritional, cognitive, sexual, and behavioral associated with psychotropic medications.
Specify how medications are chosen for mood disorders and specific patient characteristics.
Compile medication treatment options for your clients with ADHD.
Determine the unique medication considerations for geriatric clients.
Determine acute and chronic pain and methods of treatment.
Analyze future trends, including preventing side effects vs. managing side effects.
Establish ethical issues specifically relating to the child and adolescent population as it relates to clinical psychopharmacology.
Apply traditional standards (autonomy, beneficence, nonmaleficence, confidentiality, veracity) of ethical behavior to issues peculiar to the practice of clinical psychopharmacology.
Explore specific ethical issues and their resolve to the everyday practice of clinical psychopharmacology.

DAY ONE

PSYCHOPHARMACOLOGY

Historical antecedents of modern psychopharmacology
Diagnostic issues
Clarification of terms
Drug metabolism concepts: pharmacokinetics & pharmacodynamics
Drug mechanism of action
Placebo & Nocebo
Pharmacotherapy vs. Pharmacotherapy
Developing highly effective collaborations with prescribers

DEPRESSIVE DISORDERS

Biogenic Amine, Cortisol, Down-Regulation, & Neurotropic Hypotheses
Neurochemistry of depression
Types of anti-depressants
Preventing side effects
Tardive Dysphoria: real or imagined?

ANXIETY DISORDERS & OBSESSIVE COMPULSIVE DISORDERS & TRAUMA RELATED DISORDERS

Neurochemistry of anxiety
GAD, panic disorders, phobias
OCD
PTSD
Physiological interventions
Anti-anxiety medications
Anti-depressants
Non-pharmacologic options
Benzodiazepines: risks and benefits
Preventing side effects

BIPOLAR DISORDERS

Neurochemistry
The Bipolar Spectrum & DSM-5® Changes
Mood stabilizers
- Lithium
- Anti-convulsants & neuromodulators
Typical, atypical, & third-generation antipsychotics
Effective strategies for improving outcomes for clients

PSYCHOTIC DISORDERS/ SCHIZOPHRENIA

Neurochemistry of psychosis and schizophrenia
Antipsychotic Medications:
- First generation (typical)
- Second generation (atypical)
Managing side effects
- Extrapyramidal symptoms and TD
- Metabolic problems- what blood tests are needed and when
- Preventing Diabetes Mellitus
Recognizing hyperprolactinemia- and why you need to know
Use of atypical antipsychotics for multiple disorders

LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

DAY TWO

ATTENTIONAL DISORDERS

Differential diagnosis
Neurochemistry of ADHD
Treatment controversies
Substance abuse and ADHD
Stimulant medications
Non-stimulant options
Preventing side effects

SUBSTANCE ABUSE DISORDERS

Neurochemistry of addiction
Negative reinforcement & creation of habits
Alcohol
Caffeine
Nicotine
Cannabis
Opiates
PCP & Ketamine
MDMA (Ecstasy)
Energy vs. Chill Drinks
Over-the-counter & herbal psychopharmacology
Addiction treatments
Behavioral addictions

SPECIAL POPULATIONS

Specialized guidelines for geriatric patients
Dementia treatment
Slow vs. rapid metabolizers (genetic polymorphisms)

TREATING CLIENTS PAIN

Acute vs. chronic pain
Alternatives to pharmacology
Pain vs. depression: which comes first?

ETHICS & PSYCHOPHARMACOLOGY

High-risk pharmacology & psychopharmacology
Off-label use of medications
Prescribing for children
Elective psychopharmacology
Marketing of mental illness
Polypharmacy
Informed vs. uninformed consent
Patient & third party pressures
Professional boundaries
Ethics associated with medical errors
Role of placebo

FUTURE TRENDS

Change of mind: preventing vs. managing side effects
Medicalization of normal
Computer assisted devices
New meds, new diagnoses, new theories, new normal
Top 10 Medical Emergencies
Integrating psychotherapy with psychopharmacology

LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

Tag: Psychopharmacology 2-Day Conference – Perry W. Buffington Review. Psychopharmacology 2-Day Conference – Perry W. Buffington download. Psychopharmacology 2-Day Conference – Perry W. Buffington discount.

Delivery Method

– After your purchase, you’ll see a View your orders link which goes to the Downloads page. Here, you can download all the files associated with your order.
– Downloads are available once your payment is confirmed, we’ll also send you a download notification email separate from any transaction notification emails you receive from NLPlib course.
– Since it is a digital copy, our suggestion is to download and save it to your hard drive. In case the link is broken for any reason, please contact us and we will resend the new download link.
– If you cannot find the download link, please don’t worry about that. We will update and notify you as soon as possible at 8:00 AM – 8:00 PM (UTC+8).

Thank You For Shopping With Us!